Foreign precision medical care skyrocketed 70% overnight. A shares have come to follow suit!
On Tuesday, the US stock market precision medical leader Celator was stimulated by the acquisition of Jazz Pharmaceuticals Inc. (JAZZ), which surged 71.59% a day. Prior to the impact of medical insurance control fees, domestic pharmaceutical stocks were sluggish, but with the market digestion and external disk speculation, the concept of precision medical treatment is expected to meet the trend again. On Wednesday morning, the precision medical sector was among the top gainers. Anke Biotech took the lead in daily limit, Guilin Sanjin The growth rate of Zuoli Pharmaceuticals exceeded 6%.
According to a public statement, Irish biopharmaceutical company Jazz Pharmaceuticals will acquire Celator Pharmaceuticals for $1.5 billion at a purchase price of $30.25 per share in cash, approximately twice the market value of Celator Pharmaceuticals. After the transaction is completed, JAZZ will receive experimental trials of rare blood cancers. Patent for the treatment drug VYXEOS.
The drug has been approved by the US and European regulatory authorities for the treatment of rare diseases, mainly for the treatment of rare acute myelogenous leukemia. In the future, Celator Pharmaceuticals will gain a monopoly in this field for a certain period of time.
On Tuesday, stimulated by the acquisition news, Celator Pharmaceuticals shares rose 71.11% in early trading. Since the beginning of the year, the stock has risen 1594.07%, leading the entire Nasdaq market. The market believes that Celator is likely to continue to rise. The reason why the stock is so sought after is that its new drug can significantly improve the overall survival rate of patients with high risk of acute myeloid leukemia.
Celator CEO Scott Jackson said, “Jazz Pharma and Celator are highly complementary, as both companies are committed to providing different therapies for patients whose medical needs are difficult to meet. We believe Jazz is in hematology/oncology and foundation. The clinical experience and commercial expertise of the facility contribute to the value of VYXEOS as a treatment for acute myeloid leukemia."
For the A-share market, the hype of large-scale themes tends to follow the trend of the US stocks. With the current precision medical care has been turned over in the United States, the speculation of the domestic precision medical sector will certainly not be small, especially in the bear market thinking, such defensive varieties must Will be sought after by funds.
Precision - anti-cancer
Precision medicine represents the highest level of medical development at present. The technology of detecting genes to target individual drugs and targeted drugs to specifically kill diseased cells can overcome many diseases such as cancer, cardiovascular and cerebrovascular diseases.
In April of this year, Tiger Finance reported that the US company Editas Medicine jumped 160% in two months. The pharmaceutical company is primarily focused on curing the disease by correcting the patient's defect fund, a technology that is likely to set off a medical revolution. Many venture capital firms and biopharmaceutical giants have also seen tremendous opportunities in precision medicine, including Bill Gates and Google.
The gene editing technology owned by Editas Medicine is called CRISPR. Last year, the scientific magazine called it an "annual breakthrough." To be precise, scientists enter defective genes, remove them, and replace them with healthy genes.
With the rapid development of precision medicine and the rising incidence of cancer in the world, precision medicine is getting more and more attention from the market. Among them, cellular immunotherapy as an important breakthrough in the field of tumor precision medicine, related industries are expected to usher in rapid development opportunities.
Immunotherapy is an increasingly popular cancer therapy in recent years. To put it simply, the immune system recognizes cancer cells and initiates attacks. The body's immune system is usually chosen to ignore cancer cells, and research on immunotherapy over the past few decades has been to overcome this problem.
Cancer immunotherapy mainly includes three major contents, Cell-based therapies, Antibody therapies, and Cytokine therapies. Among them, CAR-T (T cell chimeric antigen receptor) as an immune cell treatment program has attracted a lot of attention from research institutions, doctors, patients and investors worldwide. The little girl Emily Whitehead was cured by CAR-T therapy.
If you need Aneroid sphygmomanometer, Mercury sphygmomanometer or a Electronic blood pressure monitor, then you will enjoy our huge selection of high-quality blood pressure monitors here.From compact devices for the wrist to precision blood pressure monitors with large cuff circumferences for the upper arm, we offer the proper device for every requirement. If you look for Mercury sphygmomanometer, you`d better take a little time to browse the related sphygmomanometer accessories in this category so that the customer can get a replacement if there are some parts damaged.
Typically, combined with sphygmomanometer, a measurement is carried out using a Stethoscope. We have one kinds of Aneroid sphygmomanometer with attached single head stethoscope. You also can find a wide selection of single Stethoscope in other category.
Digital Blood Pressure Monitor,Medical Digital Sphygmomanometer,Digital Sphygmomanometer,Aneroid Sphygmomanometer
NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD , https://www.chinayingmed.com